pulmonary hypertension and sarcoidosis

Pulmonary arterial hypertension (PAH) and sarcoidosis are two distinct respiratory conditions. PAH is characterized by an abnormally high pressure in the pulmonary arteries, potentially leading to compromised cardiac and pulmonary function. Sarcoidosis, on the other hand, is a chronic inflammatory disorder primarily affecting the lungs but capable of involving other organs as well. There is a potential link between these two diseases, with sarcoidosis possibly precipitating PAH.

To elucidate their relationship, it's crucial to grasp the pathophysiology of sarcoidosis. In individuals with sarcoidosis, granulomas form in the lungs, potentially compressing the pulmonary arteries and thereby increasing pulmonary arterial pressure. Moreover, sarcoidosis can incite inflammation in the pulmonary vasculature, intensifying PAH symptoms. As the disease advances, patients may develop respiratory distress, fatigue, and in severe cases, this could progress to heart failure.

For patients coping with both sarcoidosis and PAH, managing their condition is paramount in daily life, including avoiding excessive exertion and emotional stress. Regular follow-ups and pulmonary function monitoring are imperative. Regarding treatment, medication should be administered under a physician's supervision, and self-medication should be avoided. Should the condition deteriorate or new symptoms emerge, prompt medical consultation is essential.